Medical Doctor Program year 2021 Reported 2019–2021 Source: CMS Open Payments, 2026 publication

Richard Demir

Obstetrics & Gynecology Chandler, AZ Medical Doctor

NPI 1255410791 CMS profile 148012

80 N McClintock Dr, Suite 104, Chandler, AZ 85226

Open in the dashboard

General payments

$45,993

98 records reported · program years 2019–2021

Research payments

$0

Paid to them · None reported · program years 2019–2021

Ownership & investment interest

$0

None reported

Through program year 2021, Richard Demir of Chandler, AZ is reported in the CMS Open Payments database as having received $45,993 across 98 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2021 General $14,684 27
2020 General $10,808 17
2019 General $20,501 54

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Richard Demir
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Richard Demir were reported at $0. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year Richard Demir Obstetrics & Gynecology median Middle half National median
2019 $20,501 $172 $62–$391 $163
2020 $10,808 $94 $36–$222 $114
2021 $14,684 $136 $42–$369 $132
2022 $0 $160 $50–$433 $149
2023 $0 $169 $56–$423 $160
2024 $0 $152 $50–$371 $164
2025 $0 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2021
  1. AbbVie, Inc. $45,051 77 payments
  2. Stryker Corporation $500 1 payment
  3. Daiichi Sankyo Inc. $205 10 payments
  4. CooperSurgical, Inc. $113 4 payments
  5. Olympus America Inc. $77 3 payments
  6. Vermillion, Inc. $18 1 payment
  7. Myovant Sciences Inc. $16 1 payment
  8. Boston Scientific Corporation $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2021
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $43,225 26 payments
  2. Food and Beverage $1,529 65 payments
  3. Travel and Lodging $739 6 payments
  4. Consulting Fee $500 1 payment
Products named General payments · program years 2019–2021
  1. Orilissa Endocrinology $20,152 38 payments
  2. ORILISSA Womens Health $17,020 22 payments
  3. ORIAHNN $15,899 19 payments
  4. GLIDE SYSTEM $500 1 payment
  5. Morphabond ER $205 10 payments
  6. ThunderBeat $77 3 payments
  7. Uterine Manipulators & Injectors $64 2 payments
  8. Endosee $49 2 payments
  9. LILETTA $26 4 payments
  10. Contained Tissue Extraction Syst $25 1 payment
  11. Other $48 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

98 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record